Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 0 | 145 | 18 | 2,078 | 40,295 |
| Gross Profit | N/A | 145 | 18 | 2,078 | 40,295 |
| Operating Expenses | 28,499 | 24,844 | 19,502 | 12,939 | 33,164 |
| Operating Income | -28,499 | -24,699 | -19,484 | -10,861 | 7,131 |
| Interest Expense | 309 | 631 | 0 | 0 | 7 |
| Other Income | 25,393 | -17,326 | 3,666 | -6,158 | 298 |
| Pre-tax Income | -3,415 | -42,656 | -15,818 | -17,019 | 7,422 |
| Income Tax | N/A | N/A | -200 | 200 | N/A |
| Net Income Continuous | -3,415 | -42,656 | -15,618 | -17,219 | 7,422 |
| Net Income | $-3,415 | $-42,656 | $-15,618 | $-17,219 | $7,422 |
| EPS Basic Total Ops | -0.36 | -6.72 | -3.48 | -4.56 | 2.28 |
| EPS Basic Continuous Ops | -0.38 | -6.70 | -3.48 | -4.54 | 2.28 |
| EPS Diluted Total Ops | -3.18 | -6.72 | -4.32 | -4.56 | 2.28 |
| EPS Diluted Continuous Ops | -0.37 | -6.70 | -3.47 | -4.54 | 2.28 |
| EPS Diluted Before Non-Recurring Items | -3.18 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-27,066 | $-24,071 | $-19,022 | $-10,592 | $7,553 |